Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

KRYS

Krystal Biotech Inc

Mar 13 • 12:45PM ET

179.09

Dollar change +0.70
Percentage change 0.39	%

Healthcare • Biotechnology • USA • NASD

Peers: AMGN BIIB REGN VRTX BMRN INCY NBIX SRPT AXSM QURE

| Held by: IJR VTI IWM VB VXF VBK XBI IJT SPSM IWO

Scroll to Statements

Index	RUT	P/E	59.94	EPS (ttm)	2.99	Insider Own	14.90%	Shs Outstand	28.79M	Perf Week	0.09%
Market Cap	5.16B	Forward P/E	16.38	EPS next Y	10.94	Insider Trans	-4.47%	Shs Float	24.51M	Perf Month	19.46%
Income	89.16M	PEG	0.90	EPS next Q	1.48	Inst Own	94.15%	Short Float	11.27%	Perf Quarter	-2.88%
Sales	290.51M	P/S	17.76	EPS this Y	137.62%	Inst Trans	-0.86%	Short Ratio	9.83	Perf Half Y	-3.19%
Book/sh	32.87	P/B	5.45	EPS next Y	53.42%	ROA	9.51%	Short Interest	2.76M	Perf Year	5.11%
Cash/sh	20.74	P/C	8.63	EPS next 5Y	66.94%	ROE	10.34%	52W Range	141.72 - 219.34	Perf YTD	14.32%
Dividend Est.	-	P/FCF	43.29	EPS past 5Y	-	ROI	9.36%	52W High	-18.35%	Beta	0.75
Dividend TTM	-	Quick Ratio	7.02	Sales past 5Y	94.60%	Gross Margin	90.80%	52W Low	26.37%	ATR (14)	7.25
Dividend Ex-Date	-	Current Ratio	7.28	EPS Y/Y TTM	1620.44%	Oper. Margin	35.52%	RSI (14)	56.11	Volatility	3.74% 4.80%
Employees	275	Debt/Eq	0.01	Sales Y/Y TTM	473.02%	Profit Margin	30.69%	Recom	1.18	Target Price	214.80
Option/Short	Yes / Yes	LT Debt/Eq	0.01	EPS Q/Q	404.61%	Payout	0.00%	Rel Volume	0.70	Prev Close	178.39
Sales Surprise	0.55%	EPS Surprise	28.37%	Sales Q/Q	116.26%	Earnings	Feb 19 BMO	Avg Volume	280.93K	Price	179.09
SMA20	1.72%	SMA50	9.60%	SMA200	0.41%	Trades		Volume	103,365	Change	0.39%

Date	Action	Analyst	Rating Change	Price Target Change
Mar-05-25	Initiated	Jefferies	Buy	$245
Aug-06-24	Downgrade	Citigroup	Buy → Neutral	$195 → $204
Nov-20-23	Initiated	Goldman	Buy	$160
Oct-24-23	Initiated	Cantor Fitzgerald	Overweight	$100
Oct-12-23	Initiated	Citigroup	Buy	$160
Sep-07-23	Initiated	Berenberg	Buy	$154
Apr-18-23	Initiated	Stifel	Buy	$102
Feb-28-23	Upgrade	Goldman	Neutral → Buy	$79 → $124
Aug-25-22	Downgrade	Goldman	Buy → Neutral	$74
Jan-18-22	Initiated	BofA Securities	Buy	$110
Jul-20-21	Upgrade	Goldman	Neutral → Buy	$73 → $90
Sep-18-20	Initiated	B. Riley FBR	Buy	$100
Jun-04-20	Initiated	Evercore ISI	Outperform	$90
Sep-24-19	Initiated	Goldman	Neutral	$60
Aug-06-19	Reiterated	H.C. Wainwright	Buy	$56 → $59
Jun-24-19	Reiterated	H.C. Wainwright	Buy	$38 → $56
Jun-24-19	Reiterated	Chardan Capital Markets	Buy	$57.50 → $75
May-30-19	Initiated	Guggenheim	Buy
Sep-11-18	Initiated	Cantor Fitzgerald	Overweight	$28

Show Previous Ratings

Feb-28-25 07:40AM	Krystal Biotech Receives Positive CHMP Opinion for VYJUVEK for the Treatment of Dystrophic Epidermolysis Bullosa (GlobeNewswire)
Feb-26-25 08:00AM	Krystal Biotech to Present at TD Cowen 45th Annual Health Care Conference (GlobeNewswire)
Feb-24-25 12:20PM	Why Krystal Biotech (KRYS) Might be Well Poised for a Surge (Zacks)
09:50AM	Why Krystal Biotech, Inc. (KRYS) is a Top Momentum Stock for the Long-Term (Zacks)
Feb-21-25 12:00PM	Krystal Biotech (KRYS) Upgraded to Buy: Here's What You Should Know (Zacks)
02:06AM	Loading…
Feb-20-25 02:06AM	Krystal Biotech Inc (KRYS) Q4 2024 Earnings Call Highlights: Record Revenue and Strategic ... (GuruFocus.com)
12:37AM	Q4 2024 Krystal Biotech Inc Earnings Call (Thomson Reuters StreetEvents)
Feb-19-25 07:00AM	Krystal Biotech Announces Fourth Quarter and Full Year 2024 Financial and Operating Results (GlobeNewswire) +12.43%
04:35AM	Krystal Biotech Inc (KRYS) Q4 2024 Earnings Report Preview: What to Look For (GuruFocus.com)
Feb-06-25 08:00AM	Krystal Biotech to Report Fourth Quarter and Full Year 2024 Financial Results on February 19, 2025 (GlobeNewswire)
Jan-24-25 09:36AM	Is the Options Market Predicting a Spike in Krystal Biotech (KRYS) Stock? (Zacks)
Jan-14-25 08:00AM	Jeune Aesthetics Appoints Nishant Saxena as Chief Financial Officer (GlobeNewswire) -5.10%
Dec-18-24 08:00AM	Krystal Biotech Announces Early Evidence of Monotherapy Activity in Heavily Pre-Treated Patients with Advanced Non-Small Cell Lung Cancer (GlobeNewswire) -7.34%
Dec-13-24 08:20AM	Krystal Biotech announces initial update for KB408, KB407 (TipRanks) -5.63%
Dec-12-24 08:00AM	Krystal Biotech Announces Initial Clinical Update for Rare Respiratory Disease Programs KB408 and KB407 Including Early Clinical Evidence of Gene Delivery to the Lung of AATD Patients and Increase in Lung AAT to Therapeutic Levels (GlobeNewswire) -7.33%
04:15PM	Loading…
Dec-09-24 04:15PM	Krystal Biotech Provides Update on EMA's Ongoing Regulatory Review of B-VEC for Dystrophic Epidermolysis Bullosa (GlobeNewswire)
Dec-04-24 11:30AM	Why Is Krystal Biotech (KRYS) Up 6.6% Since Last Earnings Report? (Zacks)
Nov-27-24 07:00AM	Krystal Biotech to Present at Upcoming Investor Conferences (GlobeNewswire)
Nov-12-24 07:00AM	Krystal Biotech to Present at Stifel 2024 Healthcare Conference (GlobeNewswire)
Nov-06-24 07:00AM	Krystal Biotech to Present at Guggenheim Securities Healthcare Innovation Conference (GlobeNewswire)
Nov-05-24 02:52AM	Q3 2024 Krystal Biotech Inc Earnings Call (Thomson Reuters StreetEvents)
02:04AM	Krystal Biotech Inc (KRYS) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ... (GuruFocus.com)
Nov-04-24 09:10AM	Krystal Biotech, Inc. (KRYS) Beats Q3 Earnings and Revenue Estimates (Zacks)
08:00AM	Krystal Biotech Announces Third Quarter 2024 Financial Results and Provides Business Updates (GlobeNewswire)
Nov-01-24 09:02AM	Earnings To Watch: Krystal Biotech Inc (KRYS) Reports Q3 2024 Results (GuruFocus.com)
08:30AM	Are Options Traders Betting on a Big Move in Krystal Biotech (KRYS) Stock? (Zacks)
Oct-28-24 10:01AM	Krystal Biotech, Inc. (KRYS) to Report Q3 Results: Wall Street Expects Earnings Growth (Zacks)
07:00AM	Krystal Biotech to Report Third Quarter 2024 Financial Results on November 4, 2024 (GlobeNewswire)
Oct-18-24 12:00PM	All You Need to Know About Krystal Biotech (KRYS) Rating Upgrade to Buy (Zacks)
Oct-16-24 03:02PM	State Street Corp's Strategic Acquisition in Krystal Biotech Inc (GuruFocus.com)
10:50AM	Loading…
Sep-21-24 10:50AM	Krystal Biotech, Inc. (KRYS): Promising Pipeline or Risky Gamble? (Insider Monkey)
Sep-18-24 01:12PM	Biotech Stock Offers A Buy Point After 256% Average Yearly Gain (Investor's Business Daily)
Sep-13-24 07:00AM	Krystal Biotech to Present at 2024 Cantor Global Healthcare Conference (GlobeNewswire)
Sep-06-24 07:00AM	Krystal Biotech to Present at H.C. Wainwright 26th Annual Global Investment Conference (GlobeNewswire)
Sep-03-24 12:20PM	Surging Earnings Estimates Signal Upside for Krystal Biotech (KRYS) Stock (Zacks)
Aug-28-24 07:00AM	Jeune Aesthetics Announces Phase 1 Positive Interim Safety and Efficacy Results for KB301 in the Treatment of Lateral Canthal Lines and Dynamic Wrinkles of the Decollete (GlobeNewswire)
07:00AM	Jeune Aesthetics Announces Phase 1 Positive Interim Safety and Efficacy Results for KB301 in the Treatment of Lateral Canthal Lines and Dynamic Wrinkles of the D collet (GlobeNewswire)
Aug-07-24 12:00PM	Krystal Biotech (KRYS) Upgraded to Buy: What Does It Mean for the Stock? (Zacks)
Aug-06-24 03:48AM	Q2 2024 Krystal Biotech Inc Earnings Call (Thomson Reuters StreetEvents)
Aug-05-24 12:59PM	Apple, Krystal Biotech fall; Tyson Foods, Kellanova rise, Monday, 8/5/2024 (Associated Press Finance) -5.85%
12:53PM	KRYS Stock Earnings: Krystal Biotech Beats EPS, Beats Revenue for Q2 2024 (InvestorPlace)
09:15AM	Krystal Biotech, Inc. (KRYS) Q2 Earnings and Revenues Top Estimates (Zacks)
08:00AM	Krystal Biotech Announces Second Quarter 2024 Financial Results and Provides Business Updates (GlobeNewswire)
Aug-01-24 08:00AM	After A 65% Run This Year, Krystal Biotech Has Plenty More In The Tank (Investor's Business Daily)
Jul-26-24 08:00AM	Krystal Biotech to Report Second Quarter 2024 Financial Results on August 5, 2024 (GlobeNewswire)
Jul-18-24 08:50AM	Krystal Biotech (KRYS) Is a Great Choice for 'Trend' Investors, Here's Why (Zacks)
Jun-25-24 06:33PM	Why Is Augmedix, Inc. (AUGX) the Most Popular AI Penny Stock Under $1? (Insider Monkey)
Jun-21-24 12:16AM	Krystal Biotech (KRYS) Surged as it Beat the Streat Estimates with Wide Margin (Insider Monkey)
Jun-11-24 02:45PM	Krystal Biotech Stock Sees RS Rating Jump To 91 (Investor's Business Daily)
Jun-07-24 06:09PM	KKR, CrowdStrike Holdings and GoDaddy Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600 (PR Newswire) +7.55%
Jun-05-24 07:00AM	Krystal Biotech to Present at Goldman Sachs 45th Annual Global Healthcare Conference (GlobeNewswire)
Jun-03-24 04:30PM	Is Krystal Biotech, Inc. (NASDAQ:KRYS) the Premier Gene Therapy Stock for Your Portfolio? (Insider Monkey)
04:17PM	9 Best Gene Therapy Stocks to Buy Now (Insider Monkey)
May-23-24 12:20PM	Earnings Estimates Moving Higher for Krystal Biotech (KRYS): Time to Buy? (Zacks)
11:07AM	Krystal Biotech (KRYS) Gains 36% Year to Date: Here's Why (Zacks)
May-15-24 07:00AM	Krystal Biotech to Present at the American Thoracic Society 2024 International Conference (GlobeNewswire)
May-08-24 07:00AM	Krystal Biotech to Present at BofA Securities 2024 Health Care Conference (GlobeNewswire)
May-07-24 11:08AM	Krystal Biotech, Inc. (NASDAQ:KRYS) Q1 2024 Earnings Call Transcript (Insider Monkey)
03:03AM	Krystal Biotech Inc (KRYS) (Q1 2024) Earnings Call Transcript Highlights: Robust Growth and ... (GuruFocus.com)
12:46AM	Q1 2024 Krystal Biotech Inc Earnings Call (Thomson Reuters StreetEvents)
May-06-24 12:53PM	KRYS Stock Earnings: Krystal Biotech Beats EPS, Misses Revenue for Q1 2024 (InvestorPlace)
09:31AM	Krystal Biotech Inc (KRYS) Surpasses Revenue Estimates in Q1 2024 (GuruFocus.com)
09:10AM	Krystal Biotech, Inc. (KRYS) Q1 Earnings and Revenues Miss Estimates (Zacks)
08:35AM	Krystal Biotech Swings to Q1 Profit -- Shares Fall (MT Newswires)
08:00AM	Krystal Biotech Announces First Quarter 2024 Financial Results and Provides Business Updates (GlobeNewswire)
May-03-24 08:40AM	Why Krystal Biotech (KRYS) Might Surprise This Earnings Season (Zacks)
May-02-24 07:00AM	Krystal Biotech to Present at the Association for Research in Vision and Ophthalmology 2024 Annual Meeting (GlobeNewswire)
Apr-26-24 07:00AM	Krystal Biotech to Report First Quarter 2024 Financial Results on May 6, 2024 (GlobeNewswire)
Apr-23-24 09:35AM	Down -7.21% in 4 Weeks, Here's Why Krystal Biotech (KRYS) Looks Ripe for a Turnaround (Zacks)
Apr-22-24 07:00AM	Krystal Biotech Announces First Patient Dosed in Phase 1 Clinical Trial of Inhaled KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors of the Lung (GlobeNewswire)
Apr-17-24 08:50AM	Krystal Biotech (KRYS) is on the Move, Here's Why the Trend Could be Sustainable (Zacks)
Apr-04-24 07:00AM	Krystal Biotech to Present at the American Association for Cancer Research 2024 Annual Meeting (GlobeNewswire)
Apr-01-24 08:50AM	Recent Price Trend in Krystal Biotech (KRYS) is Your Friend, Here's Why (Zacks)
Mar-27-24 07:44AM	3 Strong Buy Biotech Stocks to Add to Your Q2 Must-Watch List (InvestorPlace)
Mar-26-24 07:00AM	Attovia Enhances Clinical and Development Expertise with Appointment of Chief Medical Officer and Clinical and Scientific Advisory Boards (GlobeNewswire)
Mar-14-24 08:50AM	Krystal Biotech, Inc. (KRYS) Is a Great Choice for 'Trend' Investors, Here's Why (Zacks)
Mar-08-24 12:20PM	Can Krystal Biotech, Inc. (KRYS) Run Higher on Rising Earnings Estimates? (Zacks)
12:00PM	What Makes Krystal Biotech, Inc. (KRYS) a New Buy Stock (Zacks)
12:00PM	Krystal Biotech, Inc. (KRYS) is a Great Momentum Stock: Should You Buy? (Zacks)
Mar-02-24 12:00AM	Chief Accounting Officer Kathryn Romano Sells 5,000 Shares of Krystal Biotech Inc (KRYS) (GuruFocus.com)
Mar-01-24 07:31AM	2 Stocks That Could Turn $1,000 Into $2,500 in 5 Years (Motley Fool) +5.24%
Feb-28-24 11:07AM	Krystal Biotech, Inc. (NASDAQ:KRYS) Q4 2023 Earnings Call Transcript (Insider Monkey)
07:00AM	Krystal Biotech to Present at TD Cowen 44th Annual Health Care Conference (GlobeNewswire)
Feb-27-24 08:50AM	Here's Why Momentum in Krystal Biotech, Inc. (KRYS) Should Keep going (Zacks) +8.38%
Feb-26-24 11:28PM	Q4 2023 Krystal Biotech Inc Earnings Call (Thomson Reuters StreetEvents) +41.02%
09:25AM	Krystal Biotech, Inc. (KRYS) Tops Q4 Earnings and Revenue Estimates (Zacks)
08:31AM	Krystal Biotech Inc (KRYS) Reports Strong Q4 and Full Year 2023 Financial Results (GuruFocus.com)
08:00AM	Krystal Biotech Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Business Updates (GlobeNewswire)
Feb-20-24 07:00AM	Krystal Biotech to Report Fourth Quarter and Full Year 2023 Financial Results on February 26, 2024 (GlobeNewswire)
Feb-13-24 07:00AM	Krystal Biotech Receives FDA Fast Track Designation for Inhaled Oncology Candidate KB707 to Treat Solid Tumors of the Lung (GlobeNewswire) -6.17%
Feb-08-24 07:00AM	Krystal Biotech Announces Publication in the New England Journal of Medicine on the Application of B-VEC to Treat Ocular Complications in Patient with Dystrophic Epidermolysis Bullosa (GlobeNewswire)
Feb-01-24 07:00AM	Krystal Biotech to Present at Guggenheim 6th Annual Biotechnology Conference (GlobeNewswire)
Jan-24-24 11:01PM	Chief Accounting Officer Kathryn Romano Sells 2,500 Shares of Krystal Biotech Inc (GuruFocus.com) -5.86%
Jan-04-24 07:00AM	Krystal Biotech Receives Permanent J-code (J3401) for VYJUVEK (GlobeNewswire)
Dec-20-23 12:00PM	Krystal Biotech, Inc. (KRYS) Moves to Buy: Rationale Behind the Upgrade (Zacks) -5.20%
Dec-19-23 07:00AM	Krystal Biotech Receives Orphan Drug Designation from the Japanese MHLW for Beremagene Geperpavec-svdt (B-VEC) (GlobeNewswire)
Dec-10-23 11:59AM	12 Best Genomics Stocks To Buy Now (Insider Monkey)
Dec-07-23 07:03AM	Here's Why TimesSquare Capital Management U.S. Small Cap Growth Strategy Added Krystal Biotech (KRYS) (Insider Monkey)
Dec-05-23 09:55AM	Wall Street Analysts See a 42.55% Upside in Krystal Biotech, Inc. (KRYS): Can the Stock Really Move This High? (Zacks)
Nov-27-23 07:00AM	Krystal Biotech Announces EMA Validation of Marketing Authorization Application for VYJUVEK for the Treatment of Dystrophic Epidermolysis Bullosa (GlobeNewswire)

Krystal Biotech, Inc. operates as a biotechnology company, which engages in developing and commercializing pharmaceutical products. It offers the product, VYJUVEK. The company was founded by Krish S. Krishnan and Suma M. Krishnan on April 15, 2016 and is headquartered in Pittsburgh, PA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
ROMANO KATHRYN	Chief Accounting Officer	Feb 28 '25	Option Exercise	0.00	12,500	0	22,789	Feb 28 07:01 PM
ROMANO KATHRYN	Chief Accounting Officer	Feb 27 '25	Sale	175.22	750	131,415	12,604	Feb 28 07:01 PM
Krishnan Suma	President, R&D	Feb 28 '25	Option Exercise	0.00	47,500	0	1,574,926	Feb 28 07:00 PM
Krishnan Suma	President, R&D	Feb 28 '25	Option Exercise	0.00	30,000	0	1,499,125	Feb 28 07:00 PM
Krishnan Krish S	President and CEO	Feb 28 '25	Option Exercise	0.00	30,000	0	1,502,411	Feb 28 06:58 PM
Krishnan Krish S	President and CEO	Feb 28 '25	Option Exercise	0.00	47,500	0	1,570,205	Feb 28 06:58 PM
ROMANO KATHRYN	Officer	Feb 27 '25	Proposed Sale	175.22	750	131,415		Feb 27 11:52 AM
Krishnan Suma	President, R&D	Dec 13 '24	Sale	164.82	25,000	4,120,499	1,537,262	Dec 13 06:28 PM
Krishnan Suma	President, R&D	Dec 13 '24	Sale	164.78	25,000	4,119,524	1,475,882	Dec 13 06:28 PM
Krishnan Krish S	President and CEO	Dec 13 '24	Sale	164.82	25,000	4,120,499	1,537,262	Dec 13 06:27 PM
Krishnan Krish S	President and CEO	Dec 13 '24	Sale	164.78	25,000	4,119,524	1,475,882	Dec 13 06:27 PM
KRISH S KRISHNAN	Director	Dec 13 '24	Proposed Sale	173.40	25,000	4,335,000		Dec 13 04:22 PM
SUMA KRISHNAN	Director	Dec 13 '24	Proposed Sale	173.40	25,000	4,335,000		Dec 13 04:21 PM
Krishnan Suma	President, R&D	Sep 12 '24	Sale	197.77	25,000	4,944,237	1,562,262	Sep 13 05:45 PM
Krishnan Suma	President, R&D	Sep 12 '24	Sale	197.76	25,000	4,944,039	1,500,882	Sep 13 05:45 PM
Krishnan Krish S	President and CEO	Sep 12 '24	Sale	197.77	25,000	4,944,237	1,562,262	Sep 13 05:44 PM
Krishnan Krish S	President and CEO	Sep 12 '24	Sale	197.76	25,000	4,944,039	1,500,882	Sep 13 05:44 PM
SUMA KRISHNAN	Director	Sep 12 '24	Proposed Sale	198.79	25,000	4,969,750		Sep 12 04:33 PM
KRISH KRISHNAN	Director	Sep 12 '24	Proposed Sale	198.79	25,000	4,969,750		Sep 12 04:33 PM
Krishnan Suma	President, R&D	Jun 11 '24	Sale	175.77	25,000	4,394,161	1,587,262	Jun 11 08:33 PM
Krishnan Suma	President, R&D	Jun 11 '24	Sale	175.76	25,000	4,393,901	1,525,882	Jun 11 08:33 PM
Krishnan Krish S	President and CEO	Jun 11 '24	Sale	175.77	25,000	4,394,161	1,587,262	Jun 11 08:31 PM
Krishnan Krish S	President and CEO	Jun 11 '24	Sale	175.76	25,000	4,393,901	1,525,882	Jun 11 08:31 PM
Gangolli Julian S	Director	May 20 '24	Option Exercise	22.75	20,000	455,000	20,000	May 22 06:17 PM
Gangolli Julian S	Director	May 20 '24	Sale	164.13	20,000	3,282,690	0	May 22 06:17 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

KRYS

Krystal Biotech Inc

Upgrade your FINVIZ experience